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Objective: To evaluate the association of periodontal health and parameters of quality of life
assessed in 306 Chinese patients with chronic obstructive pulmonary disease (COPD).
Methods: Periodontal status and respiratory function in 306 COPD patients were clinically eval-
uated and their quality of life was assessed using the standardized St George’s Respiratory
Questionnaire (SGRQ).
Results: The SGRQ scores were all significantly correlated with major lung function parameters
(r2Z 0.37 to 0.28; all p < 0.0001) and Medical Research Council dyspnoea scale (r2Z 0.23
to 0.30; all p < 0.0001). The SGRQ scores also correlated with the 6-min walk test (r2Z 0.15
to 0.13; all p < 0.05). Of periodontal health parameters, missing tooth number and plaque
index appeared to be related to the scores of quality of life. The age- and gender-adjusted
Pearson’s correlation coefficients between missing teeth and total score, symptoms score,
and activity score were 0.09, 0.12, and 0.12, respectively (all p < 0.05). The Pearson’s corre-
lation coefficients between plaque index and symptoms score and activity score were 0.09 and
0.09 (p < 0.05). After adjusting for age, gender, body mass index, and smoking status, missing
teeth remained significantly associated with symptom score (p Z 0.030) and activity score
(p Z 0.033) while plaque index was significantly associated with symptom score (p Z 0.007).
Conclusions: Poor periodontal health as reflected by missing teeth and plaque index was signif-
icantly associated with lower quality of life in COPD patients. Our findings indicate the impor-
tance of promoting dental care in current public health strategies to improve the quality of life
in COPD patients.
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68 X. Zhou et al.Introduction
Chronic obstructive pulmonary disease (COPD) has evolved
as one of the major global causes of death and disability
over the past decades.1 Due to the alarming increase in
COPD prevalence, COPD has become a major public health
burden worldwide. It was predicted that COPD will become
the third most common cause of death and the fourth most
important disease leading to disability by the year 2020.2e4
COPD patients suffer from varying degrees of disability in
various aspects of their daily life. Lung function parameters
assessed by spirometry have been used for the past few
decades to diagnose COPD, assess disease severity, or to
evaluate treatment benefits in COPD patients.5 However,
measurements of lung function do not necessarily reflect
patients’ disability. It is well accepted that the goal of COPD
therapy should not be only to improve the physiological and
functional state, but also to minimize the impact of the
disease on the patients’ quality of life. The St George’s
Respiratory Questionnaire (SGRQ) was developed in 1991 by
Jones et al. to measure impaired health and quality of life in
chronic airway disease.6,7 In this regard, the SGRQ consists
of three specific domains: symptoms (distress due to respi-
ratory symptoms), activity (the effects due to impairment of
mobility or physical activity), and impacts (the psychosocial
effect of the disease on the individual). The SGRQ has been
translated into several languages8e10 and widely used in the
assessment of quality of life in COPD patients.11e13
COPD risk factors such as cigarette smoking and inflam-
mation may explain some of variability in quality of life in
COPD patients. There is evidence to show a possible associ-
ation between periodontitis and COPD in recent years.
Didilescu et al. indicated that dental plaque in patients with
chronic lung diseases often serves as a reservoir of bacteria
known to cause nosocomial pneumonia.14 In a systematic
review of nineteen papers addressing a possible association
between respiratory disease and oral health,15 four of them
specifically examined the relation of oral health indicators
and COPD.16e19 The evidence from these four cross-sectional
studies suggested an association between poor oral health
(including alveolar bone loss, periodontal attachment loss,
oral hygiene index, and oral plaque colonization) and chronic
pulmonary disease. Recently, two case-control studies also
found that poor periodontal health including alveolar bone
loss, and dental care were significantly associated with
increased risk of COPD.20,21 However, it remains unclear
whether and towhat extent periodontal healthwould impact
on the quality of life in COPD patients due to the lack of data.
Such information could be very useful for the development
and improvement of effective early prevention or treatment
for COPD patients. Therefore, we conducted a population
study to examine the association of periodontal health and
the quality of life as assessed by the St George’s Respiratory
Questionnaire in 306 Chinese COPD patients.
Materials and methods
Study population
In total, 306 patients with COPD were recruited from Bei-
jing ChaoYang hospital and other seven hospitals in Beijingfrom March 2007 to November 2008. Consecutive patients
were based on the following eligibility criteria: 1) aged 30
years with more than 15 teeth; 2) physician-diagnosed
COPD, post-bronchodilator forced expiratory volume in 1
second/forced vital capacity (FEV1/FVC) ratio <0.7 and
FEV1<80% of predicted value; 3) no fever, no worsening of
respiratory symptoms and no medication change within 4
weeks prior to baseline interview; 4) no primary diagnosis
of asthma; 5) no previous lung volume reduction surgery,
lung transplantation or pneumonectomy; and 6) expected
survival of at least 6 months. To ensure the compliance with
our standardized protocol at each site of all the involved
hospital, the doctors and interviewers of Beijing ChaoYang
hospital went to other seven hospitals to be responsible for
the recruitment of COPD patients. Basic demographic
variables such as age, gender, lifestyle, smoking status and
alcohol drinking status were collected by trained inter-
viewers, and anthropometric variables including height,
weight, and blood pressure were measured by nurses.
The Human Research Ethnical Board from Beijing
ChaoYang hospital approved the study, and written
informed consent was obtained from all participants.
Diagnosis of COPD and assessment of lung function
by spirometry and other respiratory tests
Criteria used for the diagnosis of COPD and classification of
severity were based on the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) spirometry guidelines:
Global Strategy for the Diagnosis, Management, and
Prevention of Chronic Obstructive Pulmonary Disease
(Update 2007).5
Lung function was measured using spirometry. The
spirometric measurements were conducted by trained and
certified technicians. During at least five forced expira-
tions, the technician attempted to obtain three acceptable
spirograms at least two of which had similar results for
forced expiratory volume (FEV) in one second (FEV1) and
forced vital capacity (FVC). The pulmonary evaluation
based on the FEV1/FVC and then using the percent of
predicted FEV1 to categorize severity. Air limitation was
defined using the fixed ratio post-bronchodilator FEV1/FVC
<0.70. Mild limitation was defined as a predicted FEV1
between 80% and 100%; moderate as a predicted FEV1
between 50% and 80%; severe as a predicted FEV1 between
30% and 50%; and very severe as a predicted FEV1 below 30%
predicted or FEV1 below 50% predicted plus the presence of
chronic respiratory failure.
The 6-min walk test (6MWT) was used as a field test to
assess the patients’ exercise capacity following the Amer-
ican Thoracic Society guideline.22 The test was performed
twice and the best performance was used for analysis. The
patients also completed the Medical Research Council
(MRC) dyspnoea scale for grading the degree of a patient’s
breathlessness.23
Assessment of life of quality using SGRQ
The SGRQ was composed of three dimensions: symptoms,
specific respiratory symptoms; activity, a measure of the
activities that cause or are limited by breathlessness; and
Periodontal health and quality of life in COPD 69impact, a measure of the overall disturbance of daily life,
social function, and well-being.7 A score was calculated for
each section and a total summary score was also calcu-
lated. The scoring range was 0e100. A high score indicated
poor health and a decrease in the score indicates an
improvement in quality of life. Mandarin-Chinese version of
the questionnaire has been demonstrated to be a reliable
and valid instrument for quality of life evaluation in COPD
patients in China.10,24 Replicate measurements were con-
ducted after one week of the first measurements. The
repeatability of the questionnaire was also high. The test-
retest intra-class correlation coefficient of total, symp-
toms, activity, and impacts scores were 0.89, 0.82, 0.89,
and 0.85, respectively.10
Periodontal examination
Oral health examinations were conducted by two trained
dentists who were blinded to the study design and patients’
COPD status. Replicate examinations were conducted
throughout the survey and intra-examiner reliability was
assessed. The Kappa value of agreement was 0.82. The
evaluation included periodontal probing, oral hygiene,
number of missing teeth, and X-ray examination of alveolar
bone. Periodontal probing included probing depth (PD),
location of the cemento-enamel junction (CEJ) to deter-
mine clinical attachment level (CAL), and bleeding index
(BI) on probing. PD and CEJ were measured with a Williams
periodontal probe at six sites of all teeth (excluding third
molars) and recorded in millimeters. Recession was recor-
ded as a positive value if the free gingival margin occurred
apical to the cemento-enamel junction, whereas it was
recoded as a negative value if it was coronal to the CEJ.
CAL was calculated using the formula PD þ CEJ Z CAL.
Bleeding index (BI) on probing was scored on a 0 to 5 scale
when any visual evidence of bleeding was noted.25 Plaque
index (PLI) for each tooth was determined on a 0 to 3 scale
after air drying.26 Alveolar bone loss was examined by using
full-mouth series of intra-oral periapical films. Bone loss at
each mesial and distal interproximal site was assessed:
1 Z alveolar bone loss less than 1/3 of root in length;
2 Z alveolar bone loss between 1/3 and 2/3 of root in
length; and 3Z alveolar bone loss more than 2/3 of root in
length. Dental caries and oral mucosal were also been
evaluated.
Statistical analysis
SPSS statistical package (Version 12.0, SPSS Inc., Chicago,
IL, USA) was used for the data analysis. Basic characteris-
tics and SGRQ scores among different COPD stages were
compared using one-way ANOVA for continuous variables
and c2 test for categorical variables. Pearson’s correlation
coefficients were calculated to assess the correlations of
the SGRQ scores with respiratory system measures and
periodontal indexes. To control for possible confounding
effects, linear regression analysis was performed to calcu-
late the SGRQ scores in relation to periodontal indexes. In
the multivariate-adjusted models, we included age,
gender, body mass index (BMI), and smoking status as
covariates.Results
Basic characteristics of the patients and their SGRQ
scores
The basic characteristics of the 306 COPD patients including
their SGRQ scores are presented in Table 1. We identified 34
mild COPD (Stage I), 146 moderate COPD (Stage II), 98
severe COPD (Stage III), and 28 very severe COPD patients
(Stage IV). The mean age (SD) of the COPD Stage I to IV
were 65.6  8.62 years, 64.4  10.3 years, 63.1  9.24
years, and 62.3  11.0 years, respectively. The proportions
of men were 52.9%, 69.2%, 70.4%, and 78.6%, respectively.
As expected, the advanced COPD stages were significantly
associated with lower FEV1% of predicted, FEV1/FVC, and
6MWT. The mean predicted FEV1% of the COPD stage I to IV
were 91.0  10.5, 63.7  9.61, 41.3  5.40, and
24.1  5.71, respectively (p < 0.0001). The mean 6MWT
were 429  70.4, 443  97.9, 418  98.2, and 377  82.5,
respectively (p Z 0.01). The advanced COPD stages were
also associated with higher MRC dyspnoea scale and SGRQ
scores (total score, symptoms score, activity score, and
impacts score). The mean MRC dyspnoea scale were
1.82  0.46, 2.38  0.65, 2.60  0.78, and 3.25  1.11
(p < 0.0001). The mean total SGRQ scores were
31.9  7.03, 38.9  9.83, 48.7  12.6, and 55.9  15.8
(p < 0.0001).
SGRQ scores and respiratory system measures
The Pearson’s correlation coefficients between the SGRQ
scores and respiratory measures are presented in Table 2.
The SGRQ scores were negatively associated with FEV1% of
predicted, FEV1/FVC, and positively associated with MRC
dyspnoea scale; their Pearson’s correlation coefficients
were from 0.37 to 0.32, from 0.33 to 0.28, and from
0.23 to 0.30, respectively (all p < 0.0001). The SGRQ scores
and 6MWT were also correlated (Pearson’s correlation
coefficient from 0.15 to 0.09; p < 0.05).
Periodontal indexes and SGRQ scores
Age- and gender-adjusted Pearson’s correlation coefficients
between periodontal indexes and the SGRQ scores are
presented in Table 3. Missing teeth was positively associ-
ated with total scare, symptoms score, and activity score;
their Pearson’s correlation coefficients were 0.09, 0.12,
and 0.12, respectively (p < 0.05). Plaque index was also
positively associated with symptoms score and activity
score, the Pearson’s correlation coefficients were 0.09 and
0.09 (p < 0.05).
Linear regression analysis of SGRQ scores in
relation to periodontal indexes
We used the linear regression to analyze the SGRQ scores in
relation to periodontal indexes (Table 4). In the crude
model, missing teeth was significantly associated with total
scores (p Z 0.037), symptoms score (p Z 0.013) and
activity score (p < 0.0001); plaque index was significantly
Table 1 Basic characteristics of 306 COPD patients and their SGRQ scores in the study.
Characteristic COPD Stage
I: Mild
(n Z 34)
II: Moderate
(n Z 146)
III: Severe
(n Z 98)
IV: Very severe
(n Z 28)
p value*
Distribution of subject (%)
Gender 0.15
Men 18 (52.9) 101 (69.2) 69 (70.4) 22 (78.6)
Women 16 (47.1) 45 (37.8) 29 (29.6) 6 (21.4)
Smoking status 0.06
Non-smoker 18 (52.9) 52 (36.1) 26 (26.5) 9 (32.1)
Former smoker 12 (35.3) 65 (45.1) 59 (60.2) 17 (60.7)
Current smoker 4 (11.8) 27 (18.8) 13 (13.3) 2 (7.10)
Mean  standard deviation (SD)
Age 65.5  8.62 64.4  10.2 63.1 9.24 62.3  11.0 0.43
BMI 25.8  3.90 25.2  3.15 24.0  3.53 25.5  6.70 0.03
FEV1% of predicted 91.0  10.5 63.7  9.61 41.3  5.40 24.1  5.71 <0.0001
FEV1/FVC 68.0  4.38 58.7  9.50 46.4  8.34 40.0  9.60 <0.0001
6MWT 429  70.4 443  97.9 418  98.2 377  82.5 0.01
MRC dyspnoea scale 1.82  0.46 2.38  0.65 2.60  0.78 3.25  1.11 <0.0001
SGRQ scores
Total 31.9  7.03 38.9  9.83 48.7  12.6 55.9  15.8 <0.0001
Symptoms 45.8  10.1 55.9  14.2 65.1  19.3 70.5  14.1 <0.0001
Activity 36.5  9.01 45.5  11.2 54.7  13.1 64.9  17.7 <0.0001
Impacts 21.2  7.57 29.8  7.98 39.7  7.46 46.0  10.7 <0.0001
*: p value obtained from one-way ANOVA for continuous variables and c2 test for categorical variables.
BMI: body mass index; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; 6MWT: 6-min walk test; MRC: Medical
Research Council; SGRQ: St George’s Respiratory Questionnaire.
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(p Z 0.001) and activity score (p Z 0.018); alveolar bone
loss was significantly associated with symptoms score
(pZ 0.038). To minimize potential confounding effect, we
adjusted for age, gender, body mass index, and smoking
status in the linear regression models. When these variables
were adjusted, missing teeth was significantly associated
with symptom score (p Z 0.030) and activity score
(p Z 0.033) and plaque index was significantly associated
with symptom score (p Z 0.007).
Discussion
In this cross-sectional study of 306 COPD patients, we found
an association between poor periodontal health and lowTable 2 Pearson’s correlation coefficients between SGRQ score
Respiratory variable SGRQ scores
Total S
FEV1% of predicted 0.37** 
FEV1/FVC 0.33** 
6MWT 0.15* 
MRC dyspnoea scale 0.29**
Age 0.07 
BMI 0.007
**: p < 0.0001 statistically significant.
*: p < 0.05 statistically significant.
SGRQ: St George’s Respiratory Questionnaire; FEV1: forced expiratory
walk test; MRC: Medical Research Council; BMI: body mass index.quality of life in COPD patients. Our results showed positive
correlations between missing teeth with the quality of life
of COPD patients, as quantified using the SGRQ total score,
symptoms score, and activity score. Plaque index was also
related with symptoms score and activity score in patients.
Our findings provided new information to support the
importance of periodontal health in the healthcare of COPD
patients.
SGRQ is a specific questionnaire most commonly used in
respiratory diseases. Compared to spirometry, it is a very
simple method that only needs an examiner and 30 minutes
to evaluate the quality of life of COPD. It could be widely
used in the assessment of overall health status in COPD
patients. Consistent with previous studies,6,27 our study
showed that severe COPD patients had higher SGRQ scores.s and respiratory system measures.
ymptoms Activity Impacts
0.36** 0.32** 0.32**
0.31** 0.29** 0.28**
0.09 0.15* 0.13*
0.30** 0.26** 0.23**
0.05 0.04 0.12*
0.05 0.003 0.009
volume in one second; FVC: forced vital capacity; 6MWT: 6-min
Table 3 Adjusted Pearson’s correlation coefficients between SGRQ scores and periodontal indexes.
Periodontal index SGRQ scores
Total Symptoms Activity Impacts
Missing teeth 0.09* 0.12* 0.12* 0.05
PD 0.06 0.05 0.02 0.07
CAL 0.03 0.009 0.008 0.06
BI 0.05 0.05 0.03 0.03
PLI 0.07 0.09* 0.09* 0.03
Alveolar bone loss 0.02 0.07 0.04 0.02
*: p < 0.05 statistically significant.
The correlations were adjusted for age and gender.
SGRQ: St George’s Respiratory Questionnaire; PD: probing depth; CAL: clinical attachment lever; BI: bleeding index; PLI: plaque index.
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scores and FEV1% of predicted, FEV1/FVC, and MRC dysp-
noea scale. SGRQ score and 6MWT also had week correla-
tions. These findings indicated the validity of using SGRQ
scores to evaluate the quality of life of COPD patients based
on the severity of lung function.
Although several studies have observed the association
between periodontal health status and COPD, to our
knowledge, this is the first study to evaluate the association
between periodontal health and quality of life in COPD
patients. We found positive correlations between missing
teeth and all SGRQ scores except for impacts score and
correlations between plaque index with symptoms score
and activity score. These findings are consistent with the
previous studies about the association between periodontal
health and COPD.16,17,28 Scannapieco et al. analyzed the
dada from the National Health and Nutrition Examination
Survey I and found individuals with a confirmed chronic
respiratory disease had significantly greater oral hygiene
index (OHI) scores than normal subjects. Subjects having
the maximum OHI value were 4.5 times more likely to have
a chronic respiratory disease than those with an OHI of 0.
Katancik et al. studied 860 elderly patients and found
among former smokers, all periodontal measures including
plaque index and CAL were associated with pulmonary
disease status.29 Results of these studies support an asso-
ciation between poor periodontal health status and COPD.
In the adjusted linear regression model, we also found
missing teeth was significantly associated with symptomTable 4 Linear regression analysis of SGRQ scores in relation to
Periodontal index p values of SGRQ scores
Total Symptoms
Crude Adjusted Crude Adj
Missing teeth 0.037* 0.16 0.013* 0.0
PD 0.06 0.06 0.16 0.6
CAL 0.98 0.20 0.16 0.8
BI 0.06 0.08 0.06 0.0
PLI 0.024* 0.07 0.001* 0.0
Alveolar bone loss 0.59 0.64 0.038* 0.3
*: p < 0.05 statistically significant.
The linear regression analyses were adjusted for age, gender, body m
SGRQ: St George’s Respiratory Questionnaire; PD: probing depth; CALscore and activity score. In addition, plaque index was
significantly associated with symptom score. Our study
found an association between poor periodontal health
status and lower quality of life as reflected as higher SGRQ
scores in COPD patients. These results suggest that a high
plaque index and severe missing teeth may be periodontal
indicators in reflecting the lower quality of life in COPD
patients.
Although the precise mechanisms are unknown, there
are several potential explanations for an association
between poor periodontal health status and the severity of
COPD. Periodontitis may be linked to COPD through
microbial species, either by supporting colonization of
respiratory pathogens in dental plaque,21 or by periodontal
pathogens and their products that can promote airway
inflammation and exacerbations. Brook’s study found
elevated antibody levels against Fusobacterium nucleatum
and Prevotella intermedia, two important periodontal
pathogens, in the sputum of patients with an acute exac-
erbation of chronic bronchitis.30 Pavord et al. suggested
that the coexistence of multiple inflammatory stimuli to
the airway maybe a key factor leading to the development
of more severe airway disease.31 A large number of
inflammatory factors are released continuously from peri-
odontal lesions and peripheral mononuclear cells and thus
induce a more severe inflammatory response. Periodontal
inflammatory stimulus may cause more severe symptoms of
COPD that subsequently could result in higher SGRQ scores
indicating poor quality of life in COPD patients.periodontal indexes.
Activity Impacts
usted Crude Adjusted Crude Adjusted
30* <0.0001* 0.033* 0.49 0.61
4 0.30 0.46 0.45 0.08
4 0.37 0.49 0.33 0.07
6 0.36 0.43 0.32 0.15
07* 0.018* 0.07 0.13 0.18
2 0.13 0.92 0.53 0.21
ass index, and smoking status.
: clinical attachment lever; BI: bleeding index; PLI: plaque index.
72 X. Zhou et al.Because this is a retrospective study, we cannot draw
any conclusion regarding a cause-and-effect association.
This can be considered a limitation of the present study.
Future interventional studies are required to assess the
efficacy of oral health care on the improvement in quality
of life of COPD patients. Also, oral health status may be
a surrogate for general health status. We cannot
completely exclude the possibility of residual confounding
by other healthy lifestyle variables. However, it seems
unlikely that such confounding effects could largely
account for our significant findings because our multivar-
iate-adjusted models controlled for important risk factors
for periodontitis and COPD including cigarette smoking. In
addition, there is a concern about potential confounding
effects by oral health behavior factors on our observations.
As discussed previously,21 oral health behavior factors were
significantly correlated with periodontal indexes. However,
if these factors are causally associated with systemic
diseases such as COPD, the most possible intermediate
pathway are periodontal conditions. To minimize possible
false negative results due to overadjustment, we didn’t
control the oral behavioral factors that are determinants of
the periodontal indexes in the regression analysis. We
believe that further investigations with longitudinal data
are required to address the relation of oral behavior factors
and periodontal health.
In conclusion, our study showed that poor periodontal
health as reflected by more missing teeth and high plaque
index was significantly associated with lower quality of life
in COPD patients. Our findings suggest that promoting
periodontal health care in COPD patients may be important
for improving their quality of life and preventing the
progression of COPD.
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